Yokohama, Japan

Rieko Nakatsu

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 2005-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rieko Nakatsu. Retrieved from https://idiyas.com/inventor/rieko-nakatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Shizuoka, JP (2005)
  • Yokohama, JP (2009)

Company Filing History:


Years Active: 2005-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rieko Nakatsu: Innovator in Pharmaceutical Development

Introduction

Rieko Nakatsu is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of protein inhibitors and antitumor agents. With a total of 2 patents, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents, Rieko has developed Hsp90 family protein inhibitors. These inhibitors comprise a benzene derivative that serves as an active ingredient, showcasing a complex formula that includes various substituents. Additionally, she has worked on piperidine derivatives, which are substituted compounds exhibiting antitumor activity and are useful as pharmaceuticals.

Career Highlights

Rieko Nakatsu is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its innovative approaches in biotechnology and pharmaceuticals. Her work has been instrumental in advancing therapeutic options for cancer treatment.

Collaborations

Rieko collaborates with notable colleagues such as Shinji Nara and Yutaka Kanda, contributing to a dynamic research environment that fosters innovation.

Conclusion

Rieko Nakatsu's contributions to pharmaceutical development highlight her role as a key inventor in the industry. Her innovative patents and collaborations continue to influence the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…